Race Oncology Future Growth
Future criteria checks 1/6
Race Oncology's earnings are forecast to decline at 6.6% per annum while its annual revenue is expected to grow at 12.3% per year. EPS is expected to decline by 4.7% per annum.
Key information
-6.6%
Earnings growth rate
-4.7%
EPS growth rate
| Biotechs earnings growth | 35.4% |
| Revenue growth rate | 12.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 5 | -16 | -15 | -15 | 1 |
| 6/30/2025 | 4 | -13 | -13 | -13 | 1 |
| 6/30/2024 | 4 | -14 | -10 | -10 | N/A |
| 3/31/2024 | 5 | -12 | -11 | -11 | N/A |
| 12/31/2023 | 6 | -11 | -13 | -13 | N/A |
| 9/30/2023 | 4 | -11 | -12 | -12 | N/A |
| 6/30/2023 | 3 | -10 | -11 | -11 | N/A |
| 3/31/2023 | 2 | -10 | -10 | -10 | N/A |
| 12/31/2022 | 1 | -11 | -9 | -9 | N/A |
| 9/30/2022 | 1 | -11 | -8 | -8 | N/A |
| 6/30/2022 | 1 | -11 | -6 | -6 | N/A |
| 3/31/2022 | 1 | -10 | -6 | -6 | N/A |
| 12/31/2021 | 1 | -9 | -6 | -6 | N/A |
| 9/30/2021 | 1 | -8 | -5 | -5 | N/A |
| 6/30/2021 | 0 | -6 | -5 | -5 | N/A |
| 3/31/2021 | 0 | -5 | -4 | -4 | N/A |
| 12/31/2020 | 0 | -4 | -3 | -3 | N/A |
| 9/30/2020 | 0 | -4 | -3 | -3 | N/A |
| 6/30/2020 | 0 | -4 | -2 | -2 | N/A |
| 3/31/2020 | 0 | -3 | -2 | -2 | N/A |
| 12/31/2019 | 0 | -3 | -2 | -2 | N/A |
| 9/30/2019 | 0 | -3 | -2 | -2 | N/A |
| 6/30/2019 | 0 | -4 | -3 | -3 | N/A |
| 3/31/2019 | 0 | -4 | -3 | -3 | N/A |
| 12/31/2018 | 0 | -5 | -3 | -3 | N/A |
| 9/30/2018 | 0 | -6 | -3 | -3 | N/A |
| 6/30/2018 | 0 | -6 | -4 | -4 | N/A |
| 3/31/2018 | 0 | -6 | N/A | -4 | N/A |
| 12/31/2017 | 0 | -6 | N/A | -4 | N/A |
| 9/30/2017 | 0 | -5 | N/A | -3 | N/A |
| 6/30/2017 | N/A | -4 | N/A | -2 | N/A |
| 3/31/2017 | N/A | -3 | N/A | -2 | N/A |
| 12/31/2016 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2016 | N/A | -1 | N/A | -1 | N/A |
| 6/30/2016 | N/A | 0 | N/A | 0 | N/A |
| 3/31/2016 | N/A | 0 | N/A | 0 | N/A |
| 12/31/2015 | N/A | 0 | N/A | 0 | N/A |
| 9/30/2015 | N/A | 0 | N/A | 0 | N/A |
| 6/30/2015 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FN3 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FN3 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FN3 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: FN3's revenue (12.3% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: FN3's revenue (12.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FN3's Return on Equity is forecast to be high in 3 years time